Litcius/Paper detail

Iruplinalkib: First Approval

Susan J. Keam

2023Drugs13 citationsDOIOpen Access PDF

Topics & Concepts

CrizotinibMedicineAnaplastic lymphoma kinaseROS1ALK inhibitorOncologyInternal medicineLung cancerTargeted therapyProtein-Tyrosine KinasesTyrosine kinaseTyrosine-kinase inhibitorCancerAdenocarcinomaMalignant pleural effusionReceptorLung Cancer Treatments and MutationsLung Cancer Research StudiesColorectal Cancer Treatments and Studies
Iruplinalkib: First Approval | Litcius